Gene by Gene | GenomeWeb

Gene by Gene

The value of consumer genomics services is increasing as customers seek to discover new cousins and adoptees track down their biological birth parents.

Consumer genomics companies have seen their databases swell with hundreds of thousands of new samples, introduced diverse offerings, and adjusted to new competitors.

NEW YORK (GenomeWeb) – Scientists from consumer genomics firm 23andMe for the first time described the Mountain View, Calif.-based company's Ancestry Composition tool in a paper.

Gene by Gene will later this year debut a genetic disease carrier screening service focused on Jewish populations in the US.

A new Y chromosome sequencing service could lead to a new generation of more informative microarrays for genetic genealogy and ancestry testing.

The term 'consumer genomics' may have a catch-all ring to it, but for the time being it means ancestry testing and genetic genealogy, including for companies such as 23andMe, which built its business on relaying both personal health information and ancestral information back to c

RootsTech is a family history conference held each year in Salt Lake City.

Gene by Gene can still the return mutation status of the BRCA1 and BRCA2 genes to US and Canadian customers via its clinical and research-focused microarrays, despite a new agreement with Myriad Genetics that prohibits Gene by Gene from offering its BRCA single-gene and gene pane

NEW YORK (GenomeWeb News) – Gene by Gene and Myriad Genetics today announced that they have reached a settlement in their litigation over BRCA testing patents held by Myriad, the University of Utah Research Foundation, HSC Research and Development Limited Partnership, Endorecherche, and the Trust

This story has been updated to include comments from Ancestry.com.
Family Tree DNA will next month begin using a new, higher-throughput microarray format to process samples for its genetic genealogy service.

Pages

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.